Spain vs Czech Republic vs Greece for IVF

Spain, the Czech Republic, and Greece are European fertility travel's big three — and they're not three versions of the same offer. Spain sells scale and the deepest donor pool at mid-premium prices; Czechia sells the continent's best value behind its strictest eligibility law; Greece sells the age statute and eligibility breadth at in-between prices. Most patients are eliminated from one of the three before preferences enter. The head-to-head:

Side by Side

Where Each Wins

Spain wins on donor-egg depth and institutional scale. The deepest pool means the shortest, most reliable matching for the widest range of phenotypes; the biggest labs run every technique at volume; and continuity (embryo storage, sibling planning, decade-later records) is institutional-grade. You pay Europe's mid-premium for it — €1,500–3,000 per cycle over Czechia — and for donor-egg patients specifically, the premium buys clinical variables, not amenities. Czechia wins on arithmetic. For the opposite-sex couples under 49 its law admits, €2,500–4,000 cycles with ICSI and first-year freezing frequently bundled turn a fixed budget into an extra attempt — and in cumulative-odds terms, an extra attempt is the most valuable thing money buys in this field. Greece wins on access. The 54-year statute is the only mainstream lawful European door for 50-plus patients; solo women excluded by Czech law get anonymity-model donation below Spanish prices; and the hybrid identity-release provision is a genuine third way no rival offers. Full country treatment in the Spain, Czech, and Greece guides.

The Second-Order Differences

Beyond law and price, three quieter variables separate the trio. Medication economics: all three run European pharmacy pricing well below US retail, with Czechia typically cheapest — worth €300–700 per stimulated cycle in the comparison. Scheduling culture: Spain's late-summer compression (August is real), Czech year-round consolidated scheduling, and Greece's gentler shoulder seasons matter to rigid treatment windows. Continuity infrastructure: Spain's institutional scale makes decade-scale storage, sibling planning, and records continuity strongest; Czech and Greek programs handle all three competently at smaller scale — a variable that weighs most for families planning multiple children from one retrieval or donor cohort.

Currency and payment mechanics are near-identical across the trio — euro invoicing, staged deposits, published cancellation schedules at the mature operators — so they cancel out of the comparison, leaving the law, the pool, and the price doing all the work. That cleanness is rare in destination comparisons and worth appreciating: the big three differ on substance, not on noise.

And a scheduling reality across all three: fresh-cycle timing follows your ovaries, not the airline — retrieval windows shift on 24–48 hours' notice everywhere, so flexible fares are a fixed cost of the model rather than a country-level differentiator.

The Decision Tree

Run eliminations first. Single, or a female couple? Czechia is out — the choice is Spain versus Greece, and it compresses to donor-pool depth versus price plus the identity-release option. Over 49? Greece stands alone. Married, under 49, own eggs? All three qualify, and the honest tiebreak is Czech arithmetic against Spanish scale — with Greece the compromise candidate that rarely wins this specific matchup but never embarrasses. Donor eggs with typical European phenotype needs? All three pools serve you; price ranks Czechia, Greece, Spain — and matching-time risk ranks in reverse, which is the whole trade. Donor eggs with phenotype needs beyond central-European or Mediterranean profiles? Spain's pool depth stops being a luxury; make it the default and let the others earn their way back with written matching-time answers. Identity access for the child matters? Greece's hybrid clinics — or exit the trio for Portugal, where identifiability is the statute rather than an option.

The Verdict

There's no best of the three — there's a best for a patient profile, and the profiles barely overlap. The couple optimizing attempts-per-budget books Prague; the solo patient or the donor-egg family optimizing match reliability books Spain; the 52-year-old, the priced-out solo patient, and the identity-curious book Greece. What all three reward identically is the standard diligence: age-banded live-birth-per-transfer numbers in writing, named laboratory leadership, itemized quotes normalized for inclusions, and cancellation tables read before deposits. The country sorts the law and the price; the clinic sorts the outcome — and that second sort, as the complete guide keeps repeating, is the one that was always yours to run.